PASQUALI, Micol
 Distribuzione geografica
Continente #
NA - Nord America 5.411
AS - Asia 2.901
EU - Europa 1.925
SA - Sud America 491
AF - Africa 58
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.806
Nazione #
US - Stati Uniti d'America 5.264
SG - Singapore 1.061
CN - Cina 771
IT - Italia 461
BR - Brasile 394
VN - Vietnam 341
PL - Polonia 329
DE - Germania 254
UA - Ucraina 211
HK - Hong Kong 203
GB - Regno Unito 169
TR - Turchia 131
FI - Finlandia 117
JP - Giappone 88
SE - Svezia 88
IN - India 80
FR - Francia 69
CA - Canada 67
RU - Federazione Russa 63
MX - Messico 58
BD - Bangladesh 44
ID - Indonesia 43
AR - Argentina 40
ZA - Sudafrica 27
ES - Italia 23
IQ - Iraq 23
NL - Olanda 23
BE - Belgio 20
AU - Australia 18
BG - Bulgaria 17
CH - Svizzera 15
UZ - Uzbekistan 15
CZ - Repubblica Ceca 14
VE - Venezuela 14
AT - Austria 12
EC - Ecuador 12
IR - Iran 11
PK - Pakistan 11
TW - Taiwan 10
CO - Colombia 9
HU - Ungheria 8
JO - Giordania 8
LT - Lituania 8
MY - Malesia 8
PH - Filippine 8
BO - Bolivia 7
JM - Giamaica 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
MA - Marocco 5
PY - Paraguay 5
AZ - Azerbaigian 4
IE - Irlanda 4
KE - Kenya 4
KG - Kirghizistan 4
KR - Corea 4
LV - Lettonia 4
NP - Nepal 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
EG - Egitto 3
ET - Etiopia 3
HN - Honduras 3
IL - Israele 3
LB - Libano 3
SA - Arabia Saudita 3
TH - Thailandia 3
UY - Uruguay 3
BB - Barbados 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
MD - Moldavia 2
PA - Panama 2
RO - Romania 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MN - Mongolia 1
MT - Malta 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
Totale 10.797
Città #
Singapore 697
Ashburn 510
San Jose 412
Woodbridge 379
Ann Arbor 354
Warsaw 327
Fairfield 307
Houston 269
Chandler 249
Jacksonville 242
Beijing 228
Santa Clara 215
Hong Kong 197
Ferrara 158
Wilmington 111
Seattle 110
The Dalles 109
Nanjing 105
Ho Chi Minh City 92
Cambridge 91
Izmir 85
Los Angeles 84
Hanoi 81
Tokyo 80
Addison 72
Dallas 72
Munich 72
New York 71
Princeton 60
Boardman 58
Dong Ket 57
Milan 50
São Paulo 50
Lauterbourg 49
Dearborn 46
Helsinki 42
Mexico City 40
Shanghai 34
Bologna 33
Redwood City 32
Orem 30
San Diego 30
Turku 30
Buffalo 29
Nanchang 28
Shenyang 28
London 24
Tianjin 23
Denver 22
Jakarta 22
Montreal 21
Stockholm 21
Council Bluffs 19
Chennai 18
Legnaro 18
Phoenix 18
Atlanta 17
Frankfurt am Main 17
Guangzhou 17
Johannesburg 17
Toronto 17
Boston 16
Hebei 16
Brussels 15
Moscow 15
Nuremberg 15
Rio de Janeiro 15
Bremen 14
Brooklyn 14
Changsha 14
Chicago 14
Tashkent 14
Falls Church 13
Belo Horizonte 12
Da Nang 12
Kunming 12
Poplar 12
San Francisco 12
Brno 11
Haiphong 11
Amsterdam 10
Jiaxing 10
Auburn Hills 9
Baghdad 9
Des Moines 9
Hefei 9
New Delhi 9
Ningbo 9
Washington 9
Brasília 8
Las Vegas 8
Mumbai 8
Ottawa 8
Reinach 8
Taizhou 8
Augusta 7
Basingstoke 7
Buenos Aires 7
Charlotte 7
Columbus 7
Totale 7.219
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 524
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 391
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 340
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 326
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 297
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 289
A solvent-extraction module for cyclotron production of high-purity technetium-99m 281
LARAMED: A Laboratory for Radioisotopes of Medical Interest 274
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 253
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 234
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 232
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 223
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 218
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 213
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 209
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 208
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 206
Extraction techniques of 99mTc from 100Mo Metal Target 200
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 199
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 192
Development of a β-spectrometer for 99gTc Activity Estimations 188
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 184
188W/188Re generator system and its therapeutic applicacions 182
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 180
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 174
CYCLOTRON-BASED ALTERNATIVE PRODUCTION OF 99mTc: INFN RESEARCH ACTIVITIES 174
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 172
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 170
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 169
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 169
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 157
Technetium complexes and radiopharmaceuticals with scorpionate ligands 154
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 153
Synthesis and labelling with the [99mTcN]2+ core of macromolecular multifunctional ligands for sentinel limphnode detection 149
The IART approach: new Re-188 nitrido biotinilated radiopharmaceuticals useful for cancer therapy 149
First Application of the IART Approach with a new Re-188 Labeled Biotin-Derivative 148
Production of 47Sc with natural vanadium targets: results of the PASTA project 144
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging 144
First in vivo imaging studies of cyclotron produced 99mTc-HMPAO 142
A remote-controlled automatic system for the labelling of lipiodol with Re-188 in the treatment of hepatocellular carcinoma 141
Synthesis and biological evaluation of a novel 99m Tc -Nitrido Labeled Substance P Derivative 138
LABELLING OF SMALL MOLECULES WITH THE 99mTc-NITRIDO CORE (cap.15) 138
LABELLING OF BIOTIN WITH 188Re 130
New [3+1] Chelating System for Rhenium (V) Nitrido Radiopharmaceuticals 126
Might Re-188 be more effective for boosting therapy of breast cancer using the IART approach? 125
Synthesis, characterizition ad X-ray crystal structure of the trigonal-planar copper (1) complex [Cu(MIBI)(3)](+) (MIBI=2-methoxyisobutylisocyanide) 124
Quality control of Tc-99m radiopharmaceuticals: influence of the generator in growth time on the final radiochemical purity 124
New "3+1" chelating system for the development of therapeutic agents lebeled with rhenium-188. 124
In vivo evaluation of nanostructured lipid labelled with 99mTc 122
New "3+1" chelating system for the development of therapeutic agents labeled with rhenium-188 121
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of Nitrido 99mTc and 188Re radiopharmaceuticals 121
PEGylated N-methly-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of Nitrido99mTc and 188Re radiopharmaceuticals 119
Novel Tc-99m radiotracer for brain imaging 117
Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P 117
Production of 67Cu by enriched 70Zn targets: First measurements of formation cross sections of 67Cu, 64Cu, 67Ga, 66Ga, 69mZn and 65Zn in interactions of 70Zn with protons above 45 MeV 113
Development of an automatic separation/extraction module for the accelerator 99mTc production from 100Mo enriched molybdenum metal targets 112
null 109
null 102
Metodo e bersaglio per la produzione di 67Cu A method and a target for the production of 67Cu 83
null 60
null 48
Totale 10.925
Categoria #
all - tutte 43.628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.572
Totale 49.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202189 0 0 0 0 0 0 0 0 0 0 0 89
2021/2022652 35 56 48 33 21 34 39 34 26 54 76 196
2022/2023560 64 61 11 75 84 80 35 47 43 9 34 17
2023/2024350 27 44 26 13 22 38 17 24 11 14 10 104
2024/20251.755 49 38 115 53 159 101 56 96 249 171 506 162
2025/20263.989 392 134 290 518 614 290 541 231 355 401 172 51
Totale 10.925